A Retrospective Study on the Factors of Drug-coated Balloon Restenosis
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The purpose of this study is to analyze potential factors post paclitaxel drug-coated balloon angioplasty in patients with Denovo large vessels disease. It includes imaging endpoints and clinical event endpoints. Over 5000 patients are expected to be enrolled.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age:
• 18 years and older.
• Diagnosis:
⁃ Diagnosed with coronary artery disease with native large vessel lesions confirmed by coronary angiography.
• Treatment Plan:
⁃ Scheduled to receive paclitaxel drug-coated balloon angioplasty.
• Informed Consent:
⁃ Patients have been fully informed about the nature and purpose of the study, and have voluntarily agreed to participate, with signed informed consent.
• Physiological Status:
⁃ Cardiac function classified as NYHA I-III.
Locations
Other Locations
China
Fuwai Central China Cardiovascular Hospital
RECRUITING
Zhengzhou
Contact Information
Primary
Quan Guo, MD
xinyiguoquan@163.com
+8615670510031
Time Frame
Start Date: 2024-10-01
Estimated Completion Date: 2026-12-01
Participants
Target number of participants: 5000
Related Therapeutic Areas
Sponsors
Leads: Henan Institute of Cardiovascular Epidemiology